23K
Downloads
287
Episodes
Are you ready to give yourself, your leaders, and every employee the opportunity to live the ideal life? In this conversation, you will hear how Entrepreneurs and their leadership teams are creating the possibility for everyone in the organization to thrive. Attract great people to your organization, retain your best people, and increase the motivation of everyone by committing to living and advocating everyone take the journey to a thriving EOS life where everyone is doing what they love with people they love, making a great contribution, being compensated appropriately, and having plenty of time for their families and other passions. If these conversations resonate with you and you want to participate in the discussion, you can catch me on LinkedIn or on my Website willcrist.com
Episodes
Wednesday Jun 13, 2012
Pilgrim Talks: Howard Leonhardt - Founder and CEO of CalstockExchange.com
Wednesday Jun 13, 2012
Wednesday Jun 13, 2012
Howard Leonhardt
Founder, Chairman & CEO
Howard Leonhardt is an inventor and serial entrepreneur. He has 21 patents for products for treating cardiovascular and heart disease. These include; cardiovascular balloon catheters, stent grafts for aneurysm repair, percutaneous heart valves, heart pacemakers with stem cell recruiting capabilities, electrical stimulation devices for promoting blood flow, electrical stimulation device for converting stem cells to heart muscle, stem cell compositions for heart repair, stem cell delivery systems, biological pacemakers and artificial lung catheter. His TALENT stent graft developed in the early 1990's holds a leading world market share for repairing aortic aneurysms without surgery. In early 1999 Leonhardt founded Bioheart, Inc. www.bioheartinc.com a leader in applying adult muscle stem cells to treat heart failure. Bioheart has raised over $105 million in paid in capital and additionally $40 million in loans and grants. Bioheart MyoCell is in Phase II/III clinical trials at 33 leading centers in the USA (The MARVEL Study). MARVEL Part I results were published in the American Heart Journal October of 2011 and demonstrated Bioheart MyoCell patients improved 95.7 meters in exercise capacity over placebo patients receiving optimal CHF drugs, whom declined minus 4 meters.- Loss of consumer confidence to buy things.
- Loss of investor confidence to invest.
- Loss of business confidence to buy and hire for growth.
- Loss of bank confidence to make loans to businesses.
- Loss of availability of credit to potential buyers
To learn more about the California Stock Exchange, go to calstockexchange.com
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.